On this World Blood Cancer Day, we honour the unique journeys of individuals affected by blood cancers and proudly collaborate with the UK haematology community to accelerate the delivery of life-saving clinical trials #WorldBloodCancerDay #BloodCancerAwareness

Thank you… it was a pleasure to discuss an important question with a high quality opponent and an expert audience! The EBMT

Dr Graham is harnessing the power of our immune system, testing a new type of CAR-T cell therapy to find a new way of treating myeloma. Whilst Chris Fox is trialling a new drug combination to treat Primary Central Nervous System Lymphoma (PCNSL).

We’re supporting AML Day to raise awareness for Acute Myeloid Leukaemia. Together we can save lives through early detection, research and better treatments. Cure Leukaemia NHS Blood+Transplant Anthony Nolan

Huge appreciation & kudos to Cure Leukaemia for your commitment and focus in resourcing delivery of 🇬🇧-led clinical trials of novel agents & cutting-edge translational science

…and what a fantastic team and stellar leadership!

Happy International Nurses’ Day ❤️ Research nurses funded by Cure Leukaemia play a vital role in delivering clinical trials, giving patients access to pioneering treatments and helping to drive global advances against blood cancer.

▶️📷Hot off the press from the EHA abstracts: 1L MRD-driven I+V results to superior 5y PFS and OS vs. ibrutinib monotherapy. #CLL #FLAIR #EHA2025 library.ehaweb.org/eha/2025/eha20…

Caroline was recruited onto the international OptiMATe trial and shares the vital role clinical trials played in her journey, and how her outcome may have been very different without access to this opportunity. Read Caroline's story: cureleukaemia.co.uk/community-blog…

Great study Sirpa Leppa - congratulations on delivering these important data! Strongly supports a biologically-risk-stratified study. Now we have more effective therapies to intervene with. Time to be RAdICAL? Watch this space 🇬🇧

So much change in R/R #DLBCL over recent years! See the updated BSH - Haematology guidelines now online onlinelibrary.wiley.com/doi/10.1111/bj…

Just released BSH R/R LBCL guideline with updated guidance on this rapidly evolving field. onlinelibrary.wiley.com/doi/10.1111/bj…

🚨 Management of relapsed or refractory large B-cell lymphoma: A British Society for Haematology Guideline Full text here: buff.ly/fIxuSNz BSH - Haematology Sridhar Chaganti Bernard Maybury Chris Fox Toby Eyre Kate Cwynarski

Hear from Dr. Pramila Krishnamurthy at King’s College Hospital as she explains the crucial role of clinical trials in advancing treatments, shaping standards of care, and transforming how blood cancer is treated. #InternationalClinicalTrialsDay

We have a new guideline! Take a look at the Management of relapsed or refractory large B-cell lymphoma here: b-s-h.org.uk/guidelines/gui…

280,000 in the UK are living with, or are in remission from leukaemia, lymphoma, myeloma, MPN or MDS. Yet all too often people don't realise these diseases are a blood cancer. Today on World Blood Cancer Day, help us spread the word, share this post, and #SayBloodCancer 🩸

CONGRESS | #ASCO25 | PRESENTATION Jeremy Abramson, MassGeneral News, shares 2-year data from STARGLO trial of Glofit-GemOx in R/R DLBCL. Sustained OS, median IRC-assessed PFS and CR benefits. Median duration of CR not reached. Safety profile remained manageable. Follow our live

🚨 New grants for healthcare professionals! We’re looking to fund projects that aim to make clinical trials more accessible, inclusive, and easier to understand, especially for under-served communities. Learn more and apply by 4th August 👇bloodcancer.org.uk/cip1

➡️➡️Big CLL news! Munir et al OS and PFS adv for MRD driven I&V over ibrutinib in 1L #CLL #EHA2025 Congrats to all FLAIR trial 🇬🇧group Measurable Residual Disease–Guided Therapy for Chronic Lymphocytic Leukemia | New England Journal of Medicine nejm.org/doi/full/10.10…

…and published today in NEJM nejm.org/doi/full/10.10…